Famotidine; Ibuprofen Patent Expiration
Famotidine; Ibuprofen is Used for relieving symptoms of rheumatoid arthritis and osteoarthritis while decreasing the risk of upper gastrointestinal ulcers in patients taking ibuprofen for these conditions. It was first introduced by Horizon Medicines Llc
Famotidine; Ibuprofen Patents
Given below is the list of patents protecting Famotidine; Ibuprofen, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Duexis | US8067033 | Stable compositions of famotidine and ibuprofen | Jul 18, 2026 | Horizon |
| Duexis | US8067451 | Methods and medicaments for administration of ibuprofen | Jul 18, 2026 | Horizon |
| Duexis | US8309127 | Stable compositions of famotidine and ibuprofen | Jul 18, 2026 | Horizon |
| Duexis | US8318202 | Stable compositions of famotidine and ibuprofen | Jul 18, 2026 | Horizon |
| Duexis | US8449910 | Stable compositions of famotidine and ibuprofen | Jul 18, 2026 | Horizon |
| Duexis | US8501228 | Stable compositions of famotidine and ibuprofen | Jul 18, 2026 | Horizon |
Famotidine; Ibuprofen's Family Patents
Explore Our Curated Drug Screens
Famotidine; Ibuprofen Generic API Manufacturers
Several generic applications have been filed for Famotidine; Ibuprofen. The first generic version for Famotidine; Ibuprofen was by Alkem Laboratories Ltd and was approved on Aug 3, 2021. And the latest generic version is by Endo Operations Ltd and was approved on Mar 22, 2024.
Given below is the list of companies who have filed for Famotidine; Ibuprofen generic, along with the locations of their manufacturing plants worldwide.
1. ALKEM LABS LTD
Alkem Laboratories Ltd has filed for 1 generic for Famotidine; Ibuprofen. This 26.6mg;800mg version comes by the name IBUPROFEN AND FAMOTIDINE. Given below are the details of the strengths of this generic introduced by Alkem Labs Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 26.6MG; 800MG
(reference standard) | tablet | Prescription | ORAL | AB | Aug 3, 2021 |
2. ASCENT PHARMS INC
Ascent Pharmaceuticals Inc has filed for 1 generic for Famotidine; Ibuprofen. This 26.6mg;800mg version comes by the name IBUPROFEN AND FAMOTIDINE. Given below are the details of the strengths of this generic introduced by Ascent Pharms Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 26.6MG; 800MG | tablet | Prescription | ORAL | AB | Mar 15, 2023 |
3. ENDO OPERATIONS
Endo Operations Ltd has filed for 1 generic for Famotidine; Ibuprofen. Given below are the details of the strengths of this generic introduced by Endo Operations.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 26.6MG; 800MG | tablet | Prescription | ORAL | AB | Mar 22, 2024 |
4. TEVA PHARMS USA
Teva Pharmaceuticals Usa has filed for 1 generic for Famotidine; Ibuprofen. This 26.6mg;800mg version comes by the name IBUPROFEN AND FAMOTIDINE. Given below are the details of the strengths of this generic introduced by Teva Pharms Usa.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 26.6MG; 800MG | tablet | Prescription | ORAL | AB | Oct 29, 2021 |
5. TORRENT
Torrent Pharmaceuticals Ltd has filed for 1 generic for Famotidine; Ibuprofen. This 26.6mg;800mg version comes by the name FAMOTIDINE AND IBUPROFEN. Given below are the details of the strengths of this generic introduced by Torrent.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 26.6MG; 800MG | tablet | Discontinued | ORAL | N/A | Mar 18, 2024 |
Manufacturing Plant Locations New
Torrent's manufacturing plants are situated in 2 countries - India, United States. Given below are the details of these plant locations as well as the firm names of Torrent as present at those locations.
| Country | City | Firm Name | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| India |
| |||||||||||
| United States |
| |||||||||||